Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Patrick Johnston

Concepts (729)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
59
2026
192
11.470
Why?
Lymphoma, Non-Hodgkin
38
2026
124
6.930
Why?
Hematopoietic Stem Cell Transplantation
35
2026
677
5.010
Why?
Visual Perception
7
2025
182
3.160
Why?
Antineoplastic Combined Chemotherapy Protocols
47
2026
1961
3.120
Why?
Transplantation, Autologous
34
2026
296
3.050
Why?
Lymphoma
18
2024
233
2.660
Why?
Immunotherapy, Adoptive
23
2026
339
2.460
Why?
Hodgkin Disease
18
2026
171
2.360
Why?
Salvage Therapy
13
2024
164
2.300
Why?
Lymphoma, B-Cell
16
2026
134
2.250
Why?
Neoplasm Recurrence, Local
25
2026
1145
2.140
Why?
Antigens, CD19
12
2024
129
2.130
Why?
Central Nervous System Neoplasms
11
2026
175
2.120
Why?
Reaction Time
6
2025
438
1.830
Why?
Visual Cortex
2
2025
84
1.610
Why?
Rituximab
28
2025
211
1.420
Why?
Lymphoma, Follicular
13
2025
56
1.410
Why?
Biological Products
9
2023
256
1.150
Why?
Aged
122
2026
25955
1.140
Why?
Everolimus
11
2018
112
1.040
Why?
Adult
128
2026
40489
1.040
Why?
Middle Aged
132
2026
35971
1.040
Why?
Humans
235
2026
144667
1.000
Why?
Male
152
2026
72431
0.940
Why?
Retrospective Studies
63
2026
17149
0.930
Why?
Granulocyte Colony-Stimulating Factor
5
2021
89
0.920
Why?
Aged, 80 and over
61
2026
8284
0.910
Why?
Young Adult
55
2026
14122
0.890
Why?
Lymphocytes
9
2026
379
0.890
Why?
Evoked Potentials
4
2025
127
0.870
Why?
Female
145
2026
78304
0.860
Why?
Disease-Free Survival
29
2023
768
0.800
Why?
Prognosis
45
2026
4312
0.800
Why?
Monocytes
9
2019
536
0.740
Why?
Antineoplastic Agents
18
2021
2201
0.720
Why?
Photic Stimulation
5
2025
264
0.710
Why?
Attention
2
2025
458
0.700
Why?
Fluorodeoxyglucose F18
8
2024
161
0.690
Why?
Peripheral Blood Stem Cell Transplantation
10
2015
35
0.690
Why?
Waldenstrom Macroglobulinemia
5
2023
20
0.690
Why?
Lymphocyte Count
17
2022
164
0.690
Why?
Sirolimus
6
2015
280
0.680
Why?
Recurrence
17
2024
1136
0.670
Why?
Lymphoma, Mantle-Cell
6
2022
33
0.660
Why?
Brain Mapping
6
2022
535
0.660
Why?
Cyclophosphamide
15
2025
265
0.650
Why?
Electroencephalography
6
2025
555
0.650
Why?
Radiopharmaceuticals
6
2021
206
0.630
Why?
Neurotoxicity Syndromes
4
2023
40
0.590
Why?
Multiple Myeloma
7
2023
306
0.590
Why?
Treatment Outcome
41
2026
11735
0.580
Why?
Doxorubicin
13
2025
398
0.560
Why?
Retinal Neoplasms
5
2018
37
0.560
Why?
Vincristine
11
2025
140
0.560
Why?
Retinal Detachment
6
2009
73
0.550
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
5
2021
76
0.550
Why?
Survival Rate
21
2021
2089
0.530
Why?
Spatial Processing
1
2017
1
0.510
Why?
Neoplasms, Second Primary
2
2017
101
0.500
Why?
Time Perception
1
2017
33
0.490
Why?
Prednisone
10
2025
221
0.490
Why?
Positron-Emission Tomography
7
2024
343
0.490
Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
97
0.480
Why?
Combined Modality Therapy
9
2024
1268
0.470
Why?
Brain
7
2021
2934
0.470
Why?
Methotrexate
4
2025
231
0.460
Why?
Transplantation Conditioning
10
2015
186
0.450
Why?
Cell Transformation, Neoplastic
5
2019
337
0.450
Why?
Drug Resistance, Neoplasm
8
2025
881
0.440
Why?
Face
1
2016
174
0.440
Why?
Stem Cell Transplantation
7
2021
190
0.440
Why?
Antibodies, Monoclonal
9
2017
1505
0.430
Why?
Vitreous Body
7
2018
117
0.430
Why?
Piperidines
5
2022
219
0.420
Why?
Survival Analysis
19
2021
1370
0.410
Why?
Autografts
6
2022
55
0.410
Why?
Antineoplastic Agents, Immunological
3
2021
201
0.410
Why?
Follow-Up Studies
24
2025
5414
0.400
Why?
Synovial Cyst
1
2013
4
0.390
Why?
Positron Emission Tomography Computed Tomography
4
2023
117
0.380
Why?
Amyloidosis
4
2018
44
0.370
Why?
Pyrimidines
6
2025
519
0.360
Why?
Antigens, CD20
5
2017
34
0.360
Why?
Wrist
1
2013
60
0.360
Why?
Lymphoma, B-Cell, Marginal Zone
3
2022
19
0.360
Why?
Fingers
1
2013
107
0.360
Why?
Pyrazoles
5
2022
512
0.360
Why?
Radioimmunotherapy
4
2017
25
0.350
Why?
Lymphoma, T-Cell
3
2015
29
0.330
Why?
Eye Neoplasms
5
2014
30
0.320
Why?
Protein-Tyrosine Kinases
3
2009
431
0.310
Why?
Adolescent
34
2026
22409
0.310
Why?
Orthopedic Procedures
1
2013
242
0.310
Why?
Lasers, Solid-State
1
2009
22
0.290
Why?
Neoplasm Proteins
4
2019
441
0.290
Why?
Burkitt Lymphoma
3
2022
62
0.280
Why?
Neoplasm Staging
12
2020
1465
0.280
Why?
Cataract Extraction
2
2009
120
0.280
Why?
Molecular Targeted Therapy
2
2010
437
0.280
Why?
Magnetic Resonance Imaging
10
2026
3888
0.280
Why?
Kaplan-Meier Estimate
12
2018
967
0.270
Why?
Risk Factors
23
2022
10796
0.270
Why?
Thalidomide
3
2018
43
0.260
Why?
Mechanistic Target of Rapamycin Complex 1
4
2018
138
0.260
Why?
Killer Cells, Natural
4
2023
470
0.260
Why?
Dexamethasone
6
2022
366
0.250
Why?
Hematopoietic Stem Cell Mobilization
3
2012
27
0.250
Why?
Pattern Recognition, Visual
2
2025
105
0.250
Why?
Lymphoma, T-Cell, Peripheral
2
2024
20
0.240
Why?
Transfusion Reaction
1
2006
61
0.240
Why?
Castleman Disease
1
2026
16
0.240
Why?
TOR Serine-Threonine Kinases
4
2017
452
0.240
Why?
Chemoradiotherapy
2
2021
239
0.230
Why?
Fracture Fixation
1
2006
79
0.230
Why?
Circulating Tumor DNA
1
2026
45
0.230
Why?
RNA, Small Interfering
2
2007
631
0.230
Why?
Hip Fractures
1
2006
86
0.230
Why?
Peripheral Nervous System Neoplasms
1
2025
19
0.230
Why?
Adaptation, Physiological
2
2022
567
0.220
Why?
Event-Related Potentials, P300
1
2025
15
0.220
Why?
Eye Injuries
3
1991
53
0.220
Why?
Central Nervous System
3
2023
279
0.220
Why?
B-Lymphocytes
6
2023
875
0.220
Why?
Thrombocytopenia
3
2022
202
0.220
Why?
Medical Oncology
2
2026
331
0.210
Why?
Skin Neoplasms
2
2022
850
0.210
Why?
Lymphohistiocytosis, Hemophagocytic
1
2024
29
0.210
Why?
Acute Kidney Injury
2
2022
869
0.210
Why?
Perioperative Care
1
2006
231
0.200
Why?
Appendicitis
1
2026
150
0.200
Why?
Conditioning, Classical
2
2022
119
0.200
Why?
Mediastinal Neoplasms
1
2024
53
0.200
Why?
Cancer Vaccines
1
2025
160
0.200
Why?
Hepatitis A
1
2024
25
0.200
Why?
Multiprotein Complexes
3
2017
171
0.200
Why?
Aqueous Humor
2
2014
38
0.200
Why?
Incidence
9
2024
2892
0.200
Why?
Fear
2
2022
366
0.200
Why?
Orientation
1
2023
50
0.190
Why?
Immunoglobulin kappa-Chains
2
2014
23
0.190
Why?
Hydroxamic Acids
2
2014
94
0.190
Why?
Predictive Value of Tests
11
2018
2117
0.190
Why?
Standard of Care
4
2025
81
0.190
Why?
Prospective Studies
15
2025
7994
0.190
Why?
Extinction, Psychological
2
2022
91
0.190
Why?
Immunologic Factors
3
2014
259
0.190
Why?
Venous Thromboembolism
2
2022
326
0.190
Why?
Cell- and Tissue-Based Therapy
4
2024
78
0.190
Why?
Cerebellum
2
2017
224
0.190
Why?
Facial Expression
1
2023
73
0.180
Why?
Vitamin D Deficiency
2
2017
187
0.180
Why?
Tomography, X-Ray Computed
4
2016
2754
0.180
Why?
Yttrium Radioisotopes
4
2017
64
0.180
Why?
Electromyography
1
2024
416
0.180
Why?
Carmustine
2
2020
52
0.180
Why?
Brain Diseases
1
2023
152
0.180
Why?
Transcription Factors
1
2010
1726
0.180
Why?
Myeloid Differentiation Factor 88
2
2019
117
0.170
Why?
Bortezomib
4
2018
54
0.170
Why?
Immunoglobulin Light Chains
3
2013
51
0.170
Why?
Cohort Studies
13
2026
5957
0.170
Why?
Facial Recognition
1
2022
35
0.170
Why?
Magnesium Deficiency
1
2021
2
0.170
Why?
Central Nervous System Diseases
1
2022
74
0.170
Why?
Status Epilepticus
1
2022
68
0.170
Why?
Hypoalbuminemia
1
2021
27
0.170
Why?
Measles virus
3
2010
21
0.170
Why?
Fluorine Radioisotopes
1
2021
14
0.170
Why?
Immunoconjugates
1
2022
138
0.170
Why?
Space Perception
1
2021
82
0.160
Why?
Bacterial Infections
1
2023
247
0.160
Why?
Autism Spectrum Disorder
2
2017
410
0.160
Why?
Magnesium
1
2021
155
0.160
Why?
Vision, Ocular
1
2020
47
0.160
Why?
Cytokines
4
2021
2045
0.160
Why?
Schizophrenia
2
2017
443
0.160
Why?
Antigens, CD34
2
2010
88
0.160
Why?
Testis
1
2021
162
0.160
Why?
Medication Systems
1
2000
3
0.160
Why?
Molecular Epidemiology
2
2017
73
0.160
Why?
Autoimmunity
2
2018
930
0.160
Why?
Filgrastim
2
2017
13
0.160
Why?
Heterocyclic Compounds
2
2012
23
0.150
Why?
Retinal Perforations
3
1996
18
0.150
Why?
Lymphopenia
2
2010
64
0.150
Why?
Automation
1
2000
104
0.150
Why?
Leukemia, B-Cell
1
2019
12
0.150
Why?
Nursing Staff
1
2000
40
0.150
Why?
Melphalan
4
2017
43
0.150
Why?
Leg
1
2021
240
0.150
Why?
Drug Administration Schedule
8
2017
779
0.150
Why?
Cost-Benefit Analysis
1
2022
638
0.150
Why?
Proportional Hazards Models
7
2023
1322
0.150
Why?
Recombinant Proteins
3
2017
1363
0.150
Why?
Protein Kinase Inhibitors
4
2019
971
0.150
Why?
Enterocolitis, Necrotizing
2
2010
41
0.150
Why?
Cues
1
2021
326
0.140
Why?
Infusions, Parenteral
1
2018
47
0.140
Why?
Time Factors
12
2019
7140
0.140
Why?
Leukocyte Count
3
2014
315
0.140
Why?
Vidarabine
4
2017
32
0.140
Why?
Mental Recall
1
2020
222
0.140
Why?
Janus Kinase 1
1
2018
26
0.140
Why?
Child
16
2026
22600
0.140
Why?
Myeloid-Derived Suppressor Cells
1
2019
70
0.140
Why?
Autistic Disorder
2
2011
211
0.130
Why?
Mutation, Missense
1
2019
338
0.130
Why?
Drug Approval
2
2010
91
0.130
Why?
Thrombosis
1
2022
396
0.130
Why?
Leukapheresis
2
2016
27
0.130
Why?
Northern Ireland
5
2009
12
0.130
Why?
Class I Phosphatidylinositol 3-Kinases
1
2018
108
0.130
Why?
Contingent Negative Variation
1
2017
9
0.130
Why?
Immunoglobulin lambda-Chains
2
2014
9
0.130
Why?
Postoperative Complications
2
2006
2950
0.130
Why?
Waste Disposal, Fluid
1
2017
53
0.130
Why?
Immunotherapy
2
2019
662
0.130
Why?
Delay Discounting
1
2017
29
0.130
Why?
Lipopolysaccharide Receptors
1
2017
87
0.130
Why?
Visual Fields
2
2017
116
0.130
Why?
Evoked Potentials, Visual
1
2017
42
0.130
Why?
Immunophenotyping
2
2015
318
0.120
Why?
Fluorouracil
2
2016
234
0.120
Why?
Maximum Tolerated Dose
4
2019
211
0.120
Why?
Tarsal Coalition
1
2016
1
0.120
Why?
Subtalar Joint
1
2016
5
0.120
Why?
Evoked Potentials, Auditory
1
2017
180
0.120
Why?
Magnetoencephalography
1
2017
161
0.120
Why?
Visual Acuity
4
1996
491
0.120
Why?
Glycine
1
2017
186
0.120
Why?
Case-Control Studies
6
2021
3603
0.120
Why?
Time-to-Treatment
1
2018
242
0.120
Why?
Mental Processes
1
2015
38
0.110
Why?
Body Fluids
1
1996
71
0.110
Why?
Uveitis
2
2014
149
0.110
Why?
Biomarkers
6
2023
4261
0.110
Why?
Dendritic Cells
1
2019
498
0.110
Why?
Odds Ratio
4
2018
1076
0.110
Why?
Myelodysplastic Syndromes
1
2017
147
0.110
Why?
Antipsychotic Agents
1
2017
214
0.110
Why?
Hemangioma, Capillary
1
1995
14
0.110
Why?
Outpatients
1
2018
447
0.110
Why?
Lymphoma, Large-Cell, Immunoblastic
1
2014
1
0.110
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
259
0.110
Why?
Comprehension
1
2017
182
0.110
Why?
Folic Acid
1
2016
198
0.110
Why?
United States
6
2025
16018
0.110
Why?
Psychotic Disorders
1
2017
185
0.110
Why?
Environmental Monitoring
1
2017
374
0.110
Why?
Boronic Acids
2
2014
36
0.110
Why?
Polyethylene Glycols
2
2017
652
0.110
Why?
Interleukin-10
2
2013
310
0.110
Why?
Translocation, Genetic
2
2022
118
0.100
Why?
Obsessive-Compulsive Disorder
1
2015
59
0.100
Why?
Optic Disk
1
1995
53
0.100
Why?
Task Performance and Analysis
1
2015
198
0.100
Why?
Water Pollutants, Chemical
1
2017
229
0.100
Why?
Prefrontal Cortex
1
2017
331
0.100
Why?
Biomarkers, Tumor
4
2013
1319
0.100
Why?
Neoplasms
2
2022
2873
0.100
Why?
Myeloid Cells
1
2015
146
0.100
Why?
Pyrazines
2
2014
92
0.100
Why?
Autoimmune Diseases
2
2018
465
0.100
Why?
Feasibility Studies
2
2016
1103
0.100
Why?
Heart Atria
1
2014
141
0.100
Why?
Polyneuropathies
1
2013
57
0.100
Why?
Intestinal Neoplasms
1
2013
30
0.100
Why?
Indoles
2
2014
504
0.100
Why?
Intestinal Perforation
1
2013
46
0.100
Why?
Tachycardia, Supraventricular
1
2013
45
0.100
Why?
Oligodeoxyribonucleotides
1
2013
140
0.090
Why?
Retinal Neovascularization
1
1993
28
0.090
Why?
Quality Assurance, Health Care
2
2008
341
0.090
Why?
Remission Induction
4
2017
309
0.090
Why?
T-Lymphocytes
3
2018
1984
0.090
Why?
POEMS Syndrome
1
2012
3
0.090
Why?
Peripheral Nerves
1
2013
71
0.090
Why?
Programmed Cell Death 1 Receptor
1
2014
264
0.090
Why?
Scleral Diseases
1
1992
2
0.090
Why?
Anti-Bacterial Agents
2
2023
1928
0.090
Why?
Hematologic Neoplasms
2
2013
163
0.090
Why?
Cell Proliferation
3
2015
2489
0.090
Why?
Disease Progression
6
2021
2847
0.090
Why?
Carbonated Beverages
1
1991
16
0.090
Why?
Corneal Diseases
1
1992
46
0.090
Why?
Epidermolysis Bullosa Dystrophica
1
1992
41
0.090
Why?
Child, Preschool
6
2026
11790
0.090
Why?
Attitude of Health Personnel
1
2000
1180
0.090
Why?
Soft Tissue Neoplasms
1
2013
128
0.090
Why?
Gene Expression Profiling
2
2011
1766
0.080
Why?
Sensitivity and Specificity
4
2026
1995
0.080
Why?
Contrast Media
2
2026
492
0.080
Why?
Stomach Neoplasms
1
2013
130
0.080
Why?
Disease Management
2
2026
650
0.080
Why?
Oncolytic Virotherapy
1
2010
13
0.080
Why?
Blast Injuries
1
1991
62
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
2
2022
238
0.080
Why?
Oncolytic Viruses
1
2010
8
0.080
Why?
Gene Targeting
1
2010
80
0.080
Why?
Samarium
1
2010
1
0.080
Why?
Myeloablative Agonists
1
2010
23
0.080
Why?
Cornea
1
1992
154
0.080
Why?
Radioisotopes
1
2010
37
0.080
Why?
Arrhythmias, Cardiac
1
2013
355
0.080
Why?
X-Ray Intensifying Screens
1
2010
3
0.080
Why?
Miosis
1
1990
4
0.080
Why?
Gray Matter
1
2011
92
0.080
Why?
Self Report
1
2015
869
0.080
Why?
Immunosuppressive Agents
1
2015
834
0.080
Why?
Short Bowel Syndrome
1
2010
27
0.080
Why?
Gene Expression Regulation, Neoplastic
2
2014
1437
0.080
Why?
Leukemia, Myeloid, Acute
1
2017
685
0.080
Why?
Surveys and Questionnaires
3
2022
6041
0.080
Why?
Holidays
1
2009
8
0.080
Why?
Child Development Disorders, Pervasive
1
2010
62
0.080
Why?
Indomethacin
1
1990
76
0.080
Why?
Radiometry
1
2010
56
0.080
Why?
Minnesota
4
2013
170
0.080
Why?
Oxazines
1
2009
37
0.080
Why?
Iris Diseases
1
1989
7
0.080
Why?
Electronics
1
2010
69
0.080
Why?
Interleukin-15
1
2010
96
0.080
Why?
Subtraction Technique
1
2009
26
0.080
Why?
Uveal Neoplasms
1
1989
16
0.070
Why?
Pain Threshold
1
2009
72
0.070
Why?
Severity of Illness Index
4
2015
2922
0.070
Why?
Organophosphorus Compounds
1
2010
84
0.070
Why?
Organometallic Compounds
1
2010
113
0.070
Why?
Lenses, Intraocular
1
1989
49
0.070
Why?
Quinolones
1
2011
202
0.070
Why?
Fatigue
2
2024
363
0.070
Why?
Radiation Dosage
1
2010
193
0.070
Why?
Multivariate Analysis
5
2012
1537
0.070
Why?
Marijuana Abuse
1
2011
210
0.070
Why?
Chromosomes, Human, Pair 6
1
2008
46
0.070
Why?
Double-Blind Method
3
2019
2033
0.070
Why?
Neurons
2
2009
1639
0.070
Why?
Treatment Failure
2
2024
365
0.070
Why?
Hospitalization
1
2018
2446
0.070
Why?
Amygdala
1
2009
198
0.070
Why?
Vancomycin Resistance
1
2007
16
0.070
Why?
Gases
1
1988
53
0.070
Why?
Fluorescein Angiography
3
1996
190
0.070
Why?
Down-Regulation
2
2007
616
0.070
Why?
Ambulatory Surgical Procedures
1
2008
79
0.070
Why?
Ophthalmoplegia
1
1987
13
0.070
Why?
Enterococcus
1
2007
22
0.070
Why?
Germinal Center
1
2008
67
0.070
Why?
Torticollis
1
1987
17
0.070
Why?
Obesity
1
2021
3070
0.070
Why?
Cytarabine
3
2017
66
0.070
Why?
Chromosomes, Human, Pair 2
1
2007
28
0.060
Why?
Chromosomes, Human, Pair 5
1
2007
28
0.060
Why?
Models, Neurological
1
2009
250
0.060
Why?
Rhinoplasty
1
2008
39
0.060
Why?
Logistic Models
4
2018
2114
0.060
Why?
Infant, Premature, Diseases
1
2008
112
0.060
Why?
Carrier State
1
2007
79
0.060
Why?
Proto-Oncogene Proteins c-bcl-6
2
2022
11
0.060
Why?
Temporal Lobe
2
2022
103
0.060
Why?
Emotions
2
2023
578
0.060
Why?
Immunohistochemistry
5
2012
1705
0.060
Why?
Vitamin D
1
2010
400
0.060
Why?
Atrial Fibrillation
1
2013
555
0.060
Why?
Ki-1 Antigen
1
2006
7
0.060
Why?
Lens, Crystalline
1
1987
83
0.060
Why?
Flow Cytometry
4
2015
1154
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2009
454
0.060
Why?
Prosthesis Implantation
1
2008
154
0.060
Why?
Diagnosis, Differential
2
2026
1501
0.060
Why?
Radiotherapy Dosage
2
2021
288
0.060
Why?
Proto-Oncogene Proteins c-jun
1
2006
54
0.060
Why?
Seat Belts
1
1986
23
0.060
Why?
Eye
1
2007
110
0.060
Why?
Quality of Life
3
2023
3183
0.060
Why?
Behavior, Animal
1
2009
521
0.060
Why?
Reproducibility of Results
4
2015
3414
0.060
Why?
ROC Curve
2
2023
618
0.060
Why?
Hematopoietic Stem Cells
2
2010
419
0.060
Why?
Cerebral Cortex
1
2009
470
0.060
Why?
Lymphocyte Depletion
1
2006
133
0.060
Why?
Anemia
2
2018
189
0.060
Why?
Neoplasm, Residual
1
2026
139
0.060
Why?
Signal Transduction
2
2010
5185
0.060
Why?
Pyridines
1
2009
603
0.060
Why?
Isoquinolines
1
2025
44
0.060
Why?
Melanoma
2
1989
757
0.060
Why?
Retreatment
2
2017
77
0.060
Why?
Amyloid
1
2006
90
0.050
Why?
Risk Assessment
4
2018
3729
0.050
Why?
Cross Infection
1
2007
263
0.050
Why?
Pregnanolone
1
2005
34
0.050
Why?
Neoplasm Grading
2
2018
310
0.050
Why?
Induction Chemotherapy
1
2025
87
0.050
Why?
Cisplatin
2
2022
339
0.050
Why?
Cognition
2
2024
1263
0.050
Why?
Thiophenes
1
2025
121
0.050
Why?
Algorithms
1
2012
1844
0.050
Why?
Vitrectomy
2
2013
73
0.050
Why?
Glaucoma
1
1987
247
0.050
Why?
Aminopterin
1
2024
3
0.050
Why?
Regression Analysis
1
2006
998
0.050
Why?
Psychiatric Status Rating Scales
2
2017
539
0.050
Why?
Proteins
1
2010
1016
0.050
Why?
Apoptosis
2
2015
2397
0.050
Why?
Biopsy
2
2019
1079
0.050
Why?
Area Under Curve
2
2017
329
0.050
Why?
Immunoglobulins, Intravenous
1
2024
133
0.050
Why?
Acute Disease
1
2026
1029
0.050
Why?
Anger
1
2023
60
0.050
Why?
HLA-DR Antigens
1
2023
220
0.050
Why?
Lactate Dehydrogenases
1
2022
6
0.050
Why?
Risk
3
2010
911
0.050
Why?
Statistics, Nonparametric
2
2017
427
0.050
Why?
Thymidylate Synthase
1
2002
13
0.050
Why?
Syndrome
1
2023
379
0.050
Why?
Creatine Kinase
1
2022
72
0.050
Why?
Cell Line, Tumor
2
2007
3523
0.050
Why?
Patient Selection
1
2006
727
0.040
Why?
Body Weight
2
2021
968
0.040
Why?
Gene Expression Regulation
1
2011
2591
0.040
Why?
Organ Size
2
2014
461
0.040
Why?
Agraphia
1
2021
1
0.040
Why?
Ki-67 Antigen
1
2002
117
0.040
Why?
Hematologic Diseases
2
2014
66
0.040
Why?
L-Lactate Dehydrogenase
2
2013
113
0.040
Why?
Pain
3
2014
785
0.040
Why?
Confusion
1
2021
30
0.040
Why?
Aphasia
1
2021
24
0.040
Why?
Wounds and Injuries
1
2009
960
0.040
Why?
Uric Acid
1
2022
166
0.040
Why?
Cell Cycle Proteins
1
2005
628
0.040
Why?
Clinical Trials as Topic
1
2006
1056
0.040
Why?
DNA-Binding Proteins
1
2008
1484
0.040
Why?
Stem Cells
1
2005
621
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2022
167
0.040
Why?
Glass
2
2009
47
0.040
Why?
Galvanic Skin Response
1
2020
26
0.040
Why?
Radiotherapy
1
2021
205
0.040
Why?
In Situ Hybridization, Fluorescence
1
2021
323
0.040
Why?
Serum Albumin
1
2021
144
0.040
Why?
Electroshock
1
2020
145
0.040
Why?
Creatinine
1
2022
509
0.040
Why?
Disease Susceptibility
1
2022
342
0.040
Why?
Manitoba
1
2000
4
0.040
Why?
Benzylamines
2
2012
43
0.040
Why?
Receptors, Antigen, T-Cell
1
2023
667
0.040
Why?
Antibodies, Monoclonal, Humanized
1
2026
990
0.040
Why?
Transplantation, Homologous
2
2013
407
0.040
Why?
Colonic Neoplasms
1
2002
256
0.040
Why?
Age Factors
2
2021
3329
0.040
Why?
Vinblastine
1
2019
75
0.040
Why?
Dacarbazine
1
2019
100
0.040
Why?
Vero Cells
2
2010
84
0.040
Why?
Medication Errors
1
2000
82
0.040
Why?
Neoplasm Invasiveness
1
2021
503
0.040
Why?
Amino Acid Substitution
1
2019
303
0.040
Why?
Administration, Oral
2
2012
851
0.040
Why?
Antibodies, Viral
1
2023
672
0.040
Why?
Cluster Analysis
2
2014
516
0.040
Why?
Immunoglobulin G
1
2023
886
0.040
Why?
Gamma Rays
1
2018
56
0.040
Why?
Intravitreal Injections
1
2018
71
0.040
Why?
Injections, Intravenous
1
2018
198
0.030
Why?
Aging
1
2009
1938
0.030
Why?
Blotting, Western
2
2015
1161
0.030
Why?
Hospitals, Teaching
1
2018
119
0.030
Why?
Chi-Square Distribution
2
2010
524
0.030
Why?
Anthracyclines
1
2018
49
0.030
Why?
Brain Neoplasms
1
2007
1327
0.030
Why?
Bleomycin
1
2019
253
0.030
Why?
Tumor Suppressor Protein p53
1
2002
532
0.030
Why?
Seizures
1
2022
477
0.030
Why?
Nursing Homes
1
2000
173
0.030
Why?
Bendamustine Hydrochloride
1
2017
17
0.030
Why?
Water Movements
1
2017
30
0.030
Why?
United Kingdom
1
2018
337
0.030
Why?
Plasma Exchange
1
2017
18
0.030
Why?
Organoplatinum Compounds
1
2017
66
0.030
Why?
Etoposide
2
2008
168
0.030
Why?
Infant
3
2024
10023
0.030
Why?
Immunoglobulin M
1
2018
281
0.030
Why?
Rain
1
2017
49
0.030
Why?
Cell Count
2
2009
320
0.030
Why?
Dose-Response Relationship, Drug
2
2011
2019
0.030
Why?
Animals
8
2015
37948
0.030
Why?
Cell Separation
2
2010
303
0.030
Why?
Green Fluorescent Proteins
2
2010
407
0.030
Why?
Neoplasms, Radiation-Induced
1
2017
100
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2011
751
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
161
0.030
Why?
Intensive Care Units
1
2022
915
0.030
Why?
Image Processing, Computer-Assisted
2
2011
779
0.030
Why?
Neutropenia
1
2017
155
0.030
Why?
Blood-Retinal Barrier
1
1996
13
0.030
Why?
Particle Size
1
2017
401
0.030
Why?
Retina
1
2018
319
0.030
Why?
von Hippel-Lindau Disease
1
1996
12
0.030
Why?
Acoustic Stimulation
1
2017
332
0.030
Why?
Fundus Oculi
1
1996
89
0.030
Why?
Registries
2
2017
2392
0.030
Why?
Chemotherapy, Adjuvant
1
2017
427
0.030
Why?
Functional Neuroimaging
1
2015
60
0.030
Why?
Extracellular Space
1
1996
119
0.030
Why?
Models, Theoretical
1
2018
578
0.030
Why?
Mechanistic Target of Rapamycin Complex 2
1
2015
62
0.030
Why?
Foot
1
2016
101
0.030
Why?
Cross-Sectional Studies
2
2017
5870
0.030
Why?
Adenine
1
2017
337
0.030
Why?
France
1
2014
40
0.030
Why?
Ankle Joint
1
2016
122
0.030
Why?
Analysis of Variance
2
2009
1301
0.030
Why?
Anxiety
1
2022
1122
0.030
Why?
Clone Cells
1
2014
263
0.030
Why?
Polyradiculoneuropathy
1
2013
5
0.030
Why?
Paraneoplastic Syndromes, Nervous System
1
2013
14
0.030
Why?
Mitral Valve Insufficiency
1
2014
68
0.030
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
20
0.030
Why?
Ambulatory Care
1
2018
607
0.030
Why?
Guillain-Barre Syndrome
1
2013
23
0.030
Why?
Transfection
2
2006
924
0.020
Why?
Sciatic Nerve
1
2013
63
0.020
Why?
Tumor Cells, Cultured
1
2015
881
0.020
Why?
Immunoassay
1
2014
105
0.020
Why?
In Vitro Techniques
1
2015
1046
0.020
Why?
Survival
1
2013
38
0.020
Why?
Lymphatic Metastasis
1
2014
334
0.020
Why?
Immunoenzyme Techniques
1
2013
197
0.020
Why?
Patient Reported Outcome Measures
1
2017
496
0.020
Why?
Device Removal
1
2014
142
0.020
Why?
In Situ Hybridization
1
2013
318
0.020
Why?
Medical Records
1
2013
191
0.020
Why?
Heart Valve Prosthesis
1
2014
129
0.020
Why?
Vision, Binocular
1
1993
47
0.020
Why?
Psychomotor Performance
1
2015
328
0.020
Why?
Plasmacytoma
1
2012
19
0.020
Why?
Transcription, Genetic
2
2011
1468
0.020
Why?
Brachytherapy
1
2013
133
0.020
Why?
Neuropsychological Tests
1
2017
1134
0.020
Why?
Horner Syndrome
1
1992
7
0.020
Why?
Heart Valve Prosthesis Implantation
1
2014
197
0.020
Why?
False Positive Reactions
1
2012
122
0.020
Why?
Research Design
1
2018
1129
0.020
Why?
Gastrointestinal Diseases
1
2014
217
0.020
Why?
Explosions
1
1991
14
0.020
Why?
Hippocampus
2
2009
966
0.020
Why?
Farnesyltranstransferase
1
2011
21
0.020
Why?
Costs and Cost Analysis
1
2012
221
0.020
Why?
Diagnostic Imaging
1
2014
341
0.020
Why?
Food Labeling
1
1991
13
0.020
Why?
Diagnostic Techniques, Ophthalmological
1
2011
53
0.020
Why?
Tomography, Optical Coherence
1
2013
270
0.020
Why?
Immunologic Techniques
1
2011
38
0.020
Why?
Interleukin-1beta
1
2013
390
0.020
Why?
Databases, Factual
1
2017
1494
0.020
Why?
RNA Splicing Factors
1
2011
66
0.020
Why?
Blood Viscosity
1
2010
19
0.020
Why?
Psychometrics
1
2015
731
0.020
Why?
Iowa
1
2010
31
0.020
Why?
Phosphorylation
1
2015
1704
0.020
Why?
Plasmapheresis
1
2010
24
0.020
Why?
Secondary Prevention
1
2012
255
0.020
Why?
Gastrointestinal Tract
1
2013
207
0.020
Why?
Intelligence Tests
1
2010
55
0.020
Why?
Cells, Cultured
2
2010
4110
0.020
Why?
Prostaglandin Antagonists
1
1990
3
0.020
Why?
Drug Therapy, Combination
2
2010
1044
0.020
Why?
Silicon
1
2010
21
0.020
Why?
Early Medical Intervention
1
2010
61
0.020
Why?
Frontal Lobe
1
2011
159
0.020
Why?
Transplantation Chimera
1
2010
55
0.020
Why?
Syk Kinase
1
2009
19
0.020
Why?
Exons
1
2011
362
0.020
Why?
Cannabinoid Receptor Antagonists
1
2009
1
0.020
Why?
Receptors, Cannabinoid
1
2009
14
0.020
Why?
Accidents, Home
1
2009
33
0.020
Why?
Poisson Distribution
1
2009
78
0.020
Why?
Administration, Topical
1
1990
152
0.020
Why?
Equipment Failure Analysis
1
2010
124
0.020
Why?
Boston
1
2009
92
0.020
Why?
Ophthalmic Solutions
1
1990
79
0.020
Why?
Medulla Oblongata
1
2009
37
0.020
Why?
Tissue Distribution
1
2010
335
0.020
Why?
Mice, SCID
1
2010
368
0.020
Why?
Inflammation
1
2021
2870
0.020
Why?
Statistics as Topic
1
2010
284
0.020
Why?
Periaqueductal Gray
1
2009
37
0.020
Why?
Formaldehyde
1
2009
64
0.020
Why?
Lacerations
1
2009
40
0.020
Why?
Cataract
1
1992
212
0.020
Why?
Endophthalmitis
1
1989
46
0.020
Why?
Random Allocation
1
1990
366
0.020
Why?
White Matter
1
2011
153
0.020
Why?
Tumor Burden
1
2010
324
0.020
Why?
Macular Edema
1
1989
49
0.020
Why?
Catheters, Indwelling
1
2009
97
0.020
Why?
Vision Disorders
1
1991
179
0.020
Why?
Morpholines
1
2009
129
0.020
Why?
Aminopyridines
1
2009
129
0.020
Why?
Atrophy
1
2009
199
0.020
Why?
Alternative Splicing
1
2011
247
0.020
Why?
Proto-Oncogene Proteins c-fos
1
2009
194
0.020
Why?
Prevalence
1
2016
2839
0.020
Why?
Rats
2
2009
5570
0.020
Why?
Intraoperative Complications
1
1990
157
0.020
Why?
Bone Marrow
1
2010
306
0.020
Why?
Diarrhea
1
2009
192
0.020
Why?
Factor Analysis, Statistical
1
2009
290
0.020
Why?
Sulfur Hexafluoride
1
1988
2
0.020
Why?
Prednisolone
1
1988
66
0.020
Why?
Chromatography, Liquid
1
2010
444
0.020
Why?
Mucositis
1
2008
20
0.020
Why?
Foreign Bodies
1
2009
110
0.020
Why?
Methods
1
1988
68
0.020
Why?
Hot Temperature
1
1991
410
0.020
Why?
Tumor Necrosis Factor-alpha
1
2013
1207
0.020
Why?
Orbital Diseases
1
1988
37
0.020
Why?
Blindness
1
1988
51
0.020
Why?
Air
1
1988
45
0.020
Why?
Lymphocyte Subsets
1
2008
79
0.020
Why?
Equipment Design
1
2010
527
0.020
Why?
Polyethylenes
1
2008
12
0.020
Why?
Silicones
1
2008
31
0.020
Why?
Vasculitis
1
1988
69
0.020
Why?
Polytetrafluoroethylene
1
2008
24
0.020
Why?
Purine-Nucleoside Phosphorylase
1
2007
6
0.020
Why?
Membrane Cofactor Protein
1
2007
14
0.020
Why?
Pneumonia
1
2014
629
0.020
Why?
Up-Regulation
1
2011
848
0.020
Why?
Sequence Deletion
1
2008
191
0.020
Why?
Vitreous Hemorrhage
1
1987
10
0.020
Why?
Leukocytes, Mononuclear
1
2010
572
0.020
Why?
Enzyme Inhibitors
1
2011
820
0.020
Why?
Timolol
1
1987
14
0.020
Why?
Pilocarpine
1
1987
16
0.020
Why?
Ifosfamide
1
2007
39
0.020
Why?
Infant, Low Birth Weight
1
2008
154
0.020
Why?
Infant, Newborn
2
2010
6399
0.020
Why?
Gene Rearrangement
1
2008
155
0.020
Why?
Drug Therapy
1
2007
80
0.020
Why?
Lymph Nodes
1
2010
501
0.020
Why?
Prodrugs
1
2007
52
0.020
Why?
Adrenal Cortex Hormones
1
2010
480
0.020
Why?
Tandem Mass Spectrometry
1
2010
565
0.020
Why?
Xenograft Model Antitumor Assays
1
2010
925
0.020
Why?
RNA-Binding Proteins
1
2011
461
0.020
Why?
Pain Measurement
1
2009
554
0.020
Why?
Birth Weight
1
2010
506
0.020
Why?
Carboplatin
1
2007
161
0.020
Why?
Cerebral Hemorrhage
1
2007
120
0.020
Why?
Trabeculectomy
1
1987
75
0.020
Why?
Cell Growth Processes
1
2006
47
0.020
Why?
Prostheses and Implants
1
2008
141
0.020
Why?
Neoplasm Metastasis
1
1989
691
0.020
Why?
Legislation as Topic
1
1986
5
0.020
Why?
Gestational Age
1
2010
980
0.020
Why?
Injections
1
2007
197
0.020
Why?
Immunocompetence
1
2006
46
0.010
Why?
Enteral Nutrition
1
2008
217
0.010
Why?
Mice
3
2010
18261
0.010
Why?
Epidemiologic Methods
1
2006
89
0.010
Why?
Choroid Neoplasms
1
1986
9
0.010
Why?
Comorbidity
1
2011
1652
0.010
Why?
Phenotype
1
2014
3147
0.010
Why?
Attention Deficit Disorder with Hyperactivity
1
2010
423
0.010
Why?
Stress, Mechanical
1
1988
494
0.010
Why?
Rabbits
1
2007
651
0.010
Why?
Gene Silencing
1
2006
202
0.010
Why?
Imaging, Three-Dimensional
1
2009
581
0.010
Why?
Tritium
1
2005
68
0.010
Why?
Myelin Basic Protein
1
2005
44
0.010
Why?
Thymidine
1
2005
60
0.010
Why?
Nestin
1
2005
19
0.010
Why?
Bromodeoxyuridine
1
2005
77
0.010
Why?
Intermediate Filament Proteins
1
2005
57
0.010
Why?
Pregnancy
2
2010
7122
0.010
Why?
Accidents, Traffic
1
1986
193
0.010
Why?
RNA Interference
1
2006
473
0.010
Why?
Glial Fibrillary Acidic Protein
1
2005
125
0.010
Why?
Genome-Wide Association Study
1
2011
1374
0.010
Why?
Transcriptional Activation
1
2006
372
0.010
Why?
Embryo, Mammalian
1
2005
232
0.010
Why?
Microtubule-Associated Proteins
1
2005
195
0.010
Why?
Software
1
2009
695
0.010
Why?
Cannabis
1
2011
509
0.010
Why?
Adenoviridae Infections
3
1958
20
0.010
Why?
Infant, Premature
1
2008
614
0.010
Why?
Biocompatible Materials
1
2008
436
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
973
0.010
Why?
Mice, Transgenic
1
2007
2184
0.010
Why?
Length of Stay
1
2008
1339
0.010
Why?
Bed Rest
1
1981
14
0.010
Why?
Pediatrics
1
2010
1121
0.010
Why?
Antimetabolites, Antineoplastic
1
2002
105
0.010
Why?
Immobilization
1
1981
53
0.010
Why?
Recovery of Function
1
2006
715
0.010
Why?
Joints
1
1982
107
0.010
Why?
Bupivacaine
1
1981
40
0.010
Why?
Colectomy
1
2002
106
0.010
Why?
Nerve Tissue Proteins
1
2005
590
0.010
Why?
Disease Models, Animal
1
2011
4539
0.010
Why?
Hypertension
1
2009
1262
0.010
Why?
Oculomotor Muscles
1
1981
86
0.010
Why?
Suture Techniques
1
1981
137
0.010
Why?
Adenoviridae
2
1958
199
0.010
Why?
Light Coagulation
1
1980
10
0.010
Why?
Gene Expression
1
2005
1476
0.010
Why?
Movement
1
1982
295
0.010
Why?
HeLa Cells
2
1958
632
0.010
Why?
Rats, Sprague-Dawley
1
2005
2521
0.010
Why?
Preoperative Care
1
1981
379
0.010
Why?
Emergency Service, Hospital
1
2009
2325
0.010
Why?
Diabetic Retinopathy
1
1980
199
0.010
Why?
RNA, Messenger
1
2005
2815
0.010
Why?
Cryotherapy
1
1996
21
0.010
Why?
Laser Coagulation
1
1996
79
0.010
Why?
Mice, Inbred C57BL
1
2005
5967
0.010
Why?
Diabetes Mellitus
1
1982
1076
0.010
Why?
Polyarteritis Nodosa
1
1988
11
0.000
Why?
Virus Diseases
2
1956
218
0.000
Why?
Kidney Failure, Chronic
1
1988
597
0.000
Why?
Hand
1
1982
161
0.000
Why?
Adenovirus Vaccines
1
1958
2
0.000
Why?
Models, Biological
1
1986
1811
0.000
Why?
Neutralization Tests
1
1956
76
0.000
Why?
Antibody Formation
1
1956
291
0.000
Why?
Viruses
1
1956
166
0.000
Why?
Cell Culture Techniques
1
1956
372
0.000
Why?
Johnston's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)